The Maharashtra Food and Drug Administration has banned three imported Pakistani beauty creams, including Goree Beauty Cream, after they were linked to severe kidney issues in 18 Nagpur women. Laboratory tests confirmed these products contain unsafe levels of mercury and lead, prompting a crackdown on their sale through e-commerce and social media.
The Maharashtra Food and Drug Administration has issued an urgent order banning the sale, distribution, and use of three specific beauty products originating from Pakistan: Goree Beauty Cream, Face Fresh Gold, and Golden Star Beauty Cream. This regulatory action follows a series of health incidents in Nagpur, where 18 women reportedly developed kidney ailments after long-term use of these whitening creams.
Toxicity Findings and Health Risks
Laboratory testing conducted on these products revealed that they are not of standard quality. The samples showed concentrations of mercury and lead that far exceed the limits permitted for cosmetic use in India. Health experts note that while mercury is sometimes used in skin-lightening products to suppress melanin, it is a toxic heavy metal that can enter the bloodstream through the skin. Prolonged exposure often leads to accumulation in vital organs, particularly the kidneys, which can cause significant and sometimes irreversible damage.
Regulatory Crackdown on Supply Channels
The presence of these banned products in the Indian market has raised serious concerns regarding the oversight of cross-border imports and the monitoring of online marketplaces. Investigations indicate that these creams were being sold through various social media pages and e-commerce platforms. In response to the growing health scare, Mumbai Police have registered a criminal case against a local shopkeeper involved in the distribution of these items.
E-commerce Platform Response
Following reports of the health crisis, Meesho has initiated an internal investigation into the matter. The company stated that it is in the process of removing the implicated products from its marketplace and emphasized that it is taking steps to ensure the safety of its platform for consumers. This incident highlights the growing challenge for regulators in tracking unregulated beauty and health products that reach Indian consumers through digital channels.
Investors and consumers should monitor for further updates from the Maharashtra FDA regarding potential expansions of this ban or additional enforcement actions against online sellers. The key concern for the broader personal care and e-commerce sector remains the strengthening of compliance protocols to prevent the sale of hazardous, unapproved imports.
